Procter & Gamble Stock Looks Pricey: What's the Best Move Now?

The Procter & Gamble Company PG continues to benefit from its strong market position, supported by ongoing productivity initiatives and a focus on cost efficiency. From a valuation standpoint, however, the stock presents a mixed picture. PG currently trades at a forward 12-month price-to-earnings (P/E) ratio of 20.22X, below its five-year median of 23.34X. Despite this discount to its historical valuation, the multiple remains above the Zacks Consumer Products – Staples industry average of 18.12X, indicating that the stock commands a premium relative to its peers.

A similar premium is evident on a price-to-sales (P/S) basis. Procter & Gamble’s P/S ratio of 3.73X stands well above the industry multiple of 2.22X. This relatively elevated valuation may limit the stock’s appeal for value-oriented investors, particularly given its Value Score of D. Taken together, these valuation metrics suggest that while PG is trading below its own historical P/E median, its premium relative to the industry warrants some caution at current levels.

Image Source: Zacks Investment Research

PG’s Premium Valuation Surpasses Peers

At a forward 12-month P/E multiple of 20.22X, Procter & Gamble trades at a notable premium to its peers, including The Clorox Company CLX, Unilever PLC UL and Albertsons Companies, Inc. ACI.

Clorox, Unilever and Albertsons Companies currently trade at forward P/E multiples of 15.01X, 16.73X and 7.03X, respectively — all well below PG’s valuation. This wide valuation gap suggests that investors are assigning a sizable premium to Procter & Gamble, making the stock appear relatively expensive compared with these peers.

PG’s elevated valuation also implies that the market is pricing in strong expectations for its future performance. While its brand strength, scale and execution capabilities may support a premium multiple, the current valuation leaves less room for disappointment. Procter & Gamble will need to deliver sustained earnings growth and solid operating performance to justify this premium. Until then, the stock appears somewhat overvalued relative to its peer group.

Despite trading at a premium valuation, Procter & Gamble’s shares have remained under pressure in recent months. In the past three months, PG stock has lost 4.5% compared with a 2.3% decline for the broader industry. The stock has also underperformed the Zacks Consumer Staples sector, which fell 1.6%, as well as the S&P 500, which gained 1.9% in the same period.

PG’s 3-Month Performance

Image Source: Zacks Investment Research

Nevertheless, Procter & Gamble has fared better than some of its peers. Shares of Clorox and Albertsons Companies have declined 8.3% and 24.1%, respectively, in the past three months. However, PG has lagged Unilever, whose shares advanced 4.6% in the same period.

At its current share price of $142.97, PG trades 14.5% below its 52-week high of $167.25 and 3.9% above its 52-week low of $137.62. The stock is also trading below its 50-day and 200-day moving averages, pointing to continued weakness in near-term price momentum. Moving averages are widely used technical indicators that help assess prevailing stock-price trends and market momentum.

Procter & Gamble Trades Below 50 & 200-Day SMA

Image Source: Zacks Investment Research

PG’s Growth Drivers vs. Market Challenges

Procter & Gamble’s growth outlook is supported by its integrated strategy centered on product superiority, innovation, productivity and stronger consumer engagement. Management highlighted improving global share trends, broad-based organic sales growth across most categories and regions, and solid momentum in markets such as Greater China and Latin America.

The company is also strengthening its core brands through product upgrades while expanding into adjacent growth opportunities. Tide’s upgraded liquid detergent, Tide evo, premium Baby Care products in China and stronger digital commerce execution illustrate how PG is using innovation to drive user growth, category expansion and market-share gains.

At the same time, productivity remains a key enabler, allowing the company to fund brand investment, media, R&D and supply-chain capabilities while supporting profitability. Procter & Gamble is also scaling AI-enabled brand building, data-driven work processes and Supply Chain 3.0 to improve speed, execution and consumer reach.

However, the operating environment remains challenging. Management expects continued volatility across consumer demand, commodities, currencies, retail dynamics and geopolitics. Fiscal 2027 guidance assumes only 1-3% organic sales growth, with restructuring creating a 30-50 basis-point headwind.

Higher raw-material, energy, transportation and supply-chain costs are expected to create about $1 billion of after-tax pressure, while foreign exchange, interest expense and lower nonoperating income add further strain. Slower category growth in North America and Europe, rising promotional intensity and continued consumer value sensitivity also pose risks.

Procter & Gamble therefore needs sustained innovation, disciplined pricing and productivity gains to offset cost pressures and return to stronger, balanced growth in the coming fiscal year.

PG’s Estimate Revision Trend

The Zacks Consensus Estimate for Procter & Gamble’s fiscal 2027 EPS has moved down 0.3% in the past 30 days. Meanwhile, the consensus mark for fiscal 2028 EPS has been unchanged in the past 30 days.

For fiscal 2027, the Zacks Consensus Estimate for PG’s revenues and EPS implies year-over-year growth of 1.8% and 1.5%, respectively. The consensus mark for fiscal 2028 revenues and EPS indicates 2.7% and 6.2% growth year over year, respectively.

Image Source: Zacks Investment Research

How to Play PG Stock Now?

Procter & Gamble’s premium valuation makes the stock relatively expensive compared with the broader industry and several key peers. Nevertheless, the elevated multiple also suggests that investors continue to place considerable confidence in the company’s strong brands, market position, innovation capabilities and long-term earnings potential, despite the recent weakness in its share price.

While productivity initiatives, portfolio strength and improving market-share trends remain encouraging, near-term growth is constrained by cost inflation, softer category growth, consumer value sensitivity and other macroeconomic uncertainties. Moreover, downward estimate revisions for fiscal 2027 warrant some caution.

Given this balance of solid underlying fundamentals and a demanding valuation, investors may prefer to retain their positions rather than chase the stock at current levels. Holding this Zacks Rank #3 (Hold) stock appears prudent until there is greater clarity on PG’s growth trajectory, margin recovery and ability to justify its premium valuation. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Procter & Gamble Company (The) (PG): Free Stock Analysis Report

Unilever PLC (UL): Free Stock Analysis Report

Albertsons Companies, Inc. (ACI): Free Stock Analysis Report

The Clorox Company (CLX): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research